To determine whether STK26’s effects on CRC cells growth, proliferation, and migration are dependent on ATF6, we utilized the ATF6 inhibitor Ceapin-A7 to experimentally verify this hypothesis. Here, ATF6 is linked to colorectal carcinoma.